Blb&B Advisors, LLC Abbott Laboratories Transaction History

Blb&B Advisors, LLC

$1.95 Billion
Q3 2024

A detailed history of Blb&B Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Blb&B Advisors, LLC holds 36,294 shares of ABT stock, worth $4.17 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

36,294

Previous 37,704 3.74%

Holding current value

$4.17 Million

Previous $3.92 Million 5.62%

% of portfolio

0.21%

Previous 0.22%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$100.07 - $118.13 $141,098 - $166,563	-1,410 Reduced 3.74%	36,294 $4.14 Million
Q2 2024 Jul 26, 2024	SELL	$100.73 - $112.44 $45,932 - $51,272	-456 Reduced 1.19%	37,704 $3.92 Million
Q1 2024 Apr 26, 2024	BUY	$109.52 - $120.96 $12,156 - $13,426	111 Added 0.29%	38,160 $4.34 Million
Q4 2023 Jan 19, 2024	SELL	$90.19 - $110.4 $45,455 - $55,641	-504 Reduced 1.31%	38,049 $4.19 Million
Q3 2023 Oct 24, 2023	SELL	$95.53 - $114.62 $43,466 - $52,152	-455 Reduced 1.17%	38,553 $3.73 Million
Q2 2023 Jul 20, 2023	SELL	$100.78 - $112.29 $22,776 - $25,377	-226 Reduced 0.58%	39,008 $4.25 Million
Q1 2023 Apr 21, 2023	SELL	$96.86 - $114.01 $80,296 - $94,514	-829 Reduced 2.07%	39,234 $3.97 Million
Q4 2022 Jan 17, 2023	SELL	$95.06 - $111.52 $67,777 - $79,513	-713 Reduced 1.75%	40,063 $0
Q3 2022 Oct 14, 2022	SELL	$96.76 - $112.03 $30,576 - $35,401	-316 Reduced 0.77%	40,776 $3.95 Million
Q2 2022 Jul 18, 2022	SELL	$102.07 - $123.37 $28,273 - $34,173	-277 Reduced 0.67%	41,092 $4.47 Million
Q1 2022 Apr 20, 2022	SELL	$114.02 - $139.04 $217,778 - $265,566	-1,910 Reduced 4.41%	41,369 $4.9 Million
Q4 2021 Jan 21, 2022	SELL	$115.53 - $141.46 $608,496 - $745,069	-5,267 Reduced 10.85%	43,279 $6.09 Million
Q3 2021 Oct 19, 2021	BUY	$116.66 - $129.06 $87,844 - $97,182	753 Added 1.58%	48,546 $5.74 Million
Q2 2021 Jul 20, 2021	BUY	$105.79 - $124.53 $27,928 - $32,875	264 Added 0.56%	47,793 $5.54 Million
Q1 2021 Apr 19, 2021	SELL	$108.84 - $128.23 $695,922 - $819,902	-6,394 Reduced 11.86%	47,529 $5.7 Million
Q4 2020 Jan 19, 2021	BUY	$105.0 - $114.42 $181,440 - $197,717	1,728 Added 3.31%	53,923 $5.9 Million
Q3 2020 Oct 20, 2020	SELL	$91.64 - $111.29 $59,382 - $72,115	-648 Reduced 1.23%	52,195 $5.68 Million
Q2 2020 Jul 16, 2020	SELL	$76.57 - $98.0 $237,137 - $303,506	-3,097 Reduced 5.54%	52,843 $4.83 Million
Q1 2020 Apr 21, 2020	SELL	$62.82 - $91.86 $203,097 - $296,983	-3,233 Reduced 5.46%	55,940 $4.41 Million
Q4 2019 Jan 21, 2020	SELL	$78.51 - $87.4 $69,873 - $77,786	-890 Reduced 1.48%	59,173 $5.14 Million
Q3 2019 Oct 22, 2019	SELL	$81.84 - $88.74 $31,753 - $34,431	-388 Reduced 0.64%	60,063 $5.03 Million
Q2 2019 Jul 29, 2019	SELL	$72.88 - $85.0 $133,006 - $155,125	-1,825 Reduced 2.93%	60,451 $5.08 Million
Q1 2019 Apr 19, 2019	SELL	$66.22 - $80.06 $182,899 - $221,125	-2,762 Reduced 4.25%	62,276 $4.98 Million
Q4 2018 Jan 17, 2019	SELL	$65.56 - $74.27 $152,820 - $173,123	-2,331 Reduced 3.46%	65,038 $4.7 Million
Q3 2018 Oct 12, 2018	SELL	$60.81 - $73.36 $293,529 - $354,108	-4,827 Reduced 6.69%	67,369 $4.94 Million
Q2 2018 Jul 11, 2018	SELL	$57.57 - $63.54 $10,650 - $11,754	-185 Reduced 0.26%	72,196 $4.4 Million
Q1 2018 Apr 09, 2018	SELL	$56.27 - $63.62 $118,279 - $133,729	-2,102 Reduced 2.82%	72,381 $4.34 Million
Q4 2017 Jan 16, 2018	BUY	$53.68 - $57.47 $55,612 - $59,538	1,036 Added 1.41%	74,483 $4.25 Million
Q3 2017 Oct 16, 2017	BUY	$48.06 - $53.64 $3.53 Million - $3.94 Million	73,447	73,447 $3.92 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blb&B Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blb&B Advisors, LLC with notifications on news.

Account

Blb&B Advisors, LLC Abbott Laboratories Transaction History